Colgate-Palmolive plans to buy three pet food plants from Red Collar Pet Foods for $700 million to support the capital expenditures of its Hill’s Science Diet division business for pet foods.
Those plants, in Orangeburg, S.C.; Clinton, Okla., and Washington Court House, Ohio, will produce dry pet food, and approximately 350 employees will be offered jobs at Colgate-Palmolive.
In addition, the company is currently building a new canned pet food plant in Tonganoxie, Kansas, scheduled to begin production next year, and acquired a canned pet food plant in Italy in April.
The Hill’s Science Diet division had the fastest growth of any major Colgate-Palmolive division in the quarter ending in July.
Hill’s operating profit for that quarter was $212 million, which was about 24 percent of the profit for the company as a whole. Net sales for Hill’s products were up 15 percent, and organic sales up 18 percent.
CEO Noel Wallace said that with their business growing well, they will continue to invest to expand production capacity, improve their capabilities with initiatives like their new Small Paws Innovation Center, and better engage pet parents, veterinarians, and their retail partners.


Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Why financial hardship is more likely if you’re disabled or sick
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Youth are charting new freshwater futures by learning from the water on the water
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 



